People

Josh Wolfe

Josh Wolfe

Formal First Name
Josh

Josh Wolfe is the Co-Founder and Managing Director of Lux Capital. He is a venture investor and entrepreneur who specializes in investment in advanced material science, nanotec, nanotec, nanotec, nanotec, nanotec, nanotec, nanotec, nanotec, nanotec, nanotec, nanotechnology, and physical and life science, nanotec, nanotec, nanotec, nanotec, nanotec, nanotec, nanotec, nanotec, nanotec, nanotecs. Prior to Lux, Wolfe worked in investment banking at Salomon Smith Barney and in capital markets at Merrill Lynch. He has been invited to The White House and Capitol Hill to advise on nanotechnology and emerging technologies. He also lectures at MIT, Harvard, Yale, Cornell, Columbia, and NYU.

Professional Experience


Academic History

    CURRENT TECHNOLOGY INTERESTS

    • The rise of the GPU from gaming to power artificial intelligence and machine learning
    • Chronobiology and the science behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind o behind our body’s cellular clocks
    • Global usage of CRISPR gene editing
    • The dissolving line between bits and atoms, simulations
    • How ‘Generative Design’ is mixing technology and evolution to use computers to design future products

    CURRENT APPOINTMENTS


    INVESTMENTS (JUNE 2021)
    • Matterport

    • Luxtera
    • Compass /
    • Everspin
    • Salesconx, Inc.
    • Tempo Pharmaceuticals
    • Accelergy Corporation
    • Molecular Imprints
    • Cambrios Technologies
    • Nanosys
    • Siluria Technologies
    • Genocea Biosciences


    MEDIA AND APPEARANCES

    • Wolfe has appeared as a guest on Real Vision.
    • He has appeared as a guest at the 2021 Real Vision Festival of Learning.


    OTHERS

    • Wolfe is a published scientist and Westinghouse semi-finalist. 
    • Prior to venturing into the financial world, he published cutting-edge AIDS-immunopathology research in Cell Vision and The Journal of Leukocyte Biology.